Literature DB >> 27011877

Laser-induced breakdown spectroscopy is a reliable method for urinary stone analysis.

Nazım Mutlu1, Seyfettin Çiftçi2, Turgay Gülecen3, Belgin Genç Öztoprak4, Arif Demir4.   

Abstract

OBJECTIVE: We compared laser-induced breakdown spectroscopy (LIBS) with the traditionally used and recommended X-ray diffraction technique (XRD) for urinary stone analysis.
MATERIAL AND METHODS: In total, 65 patients with urinary calculi were enrolled in this prospective study. Stones were obtained after surgical or extracorporeal shockwave lithotripsy procedures. All stones were divided into two equal pieces. One sample was analyzed by XRD and the other by LIBS. The results were compared by the kappa (κ) and Spearman's correlation coefficient (rho) tests.
RESULTS: Using LIBS, 95 components were identified from 65 stones, while XRD identified 88 components. LIBS identified 40 stones with a single pure component, 20 stones with two different components, and 5 stones with three components. XRD demonstrated 42 stones with a single component, 22 stones with two different components, and only 1 stone with three different components. There was a strong relationship in the detection of stone types between LIBS and XRD for stones components (Spearman rho, 0.866; p<0.001). There was excellent agreement between the two techniques among 38 patients with pure stones (κ index, 0.910; Spearman rho, 0.916; p<0.001).
CONCLUSION: Our study indicates that LIBS is a valid and reliable technique for determining urinary stone composition. Moreover, it is a simple, low-cost, and nondestructive technique. LIBS can be safely used in routine daily practice if our results are supported by studies with larger numbers of patients.

Entities:  

Keywords:  Laser spectroscopy; X-ray diffraction; stone analysis; urinary calculi

Year:  2016        PMID: 27011877      PMCID: PMC4791077          DOI: 10.5152/tud.2016.76402

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  27 in total

1.  The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers.

Authors:  A Trinchieri; A Mandressi; P Luongo; G Longo; E Pisani
Journal:  Br J Urol       Date:  1991-03

2.  Quality control in urinary stone analysis: results of 44 ring trials (1980-2001).

Authors:  Albrecht Hesse; Rolf Kruse; Wolf-Jochen Geilenkeuser; Matthias Schmidt
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

3.  Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients.

Authors:  Irfan H Atakan; Mustafa Kaplan; Gulay Seren; Tevfik Aktoz; Hatice Gül; Osman Inci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

4.  Cross-sectional study of kidney stones by laser-induced breakdown spectroscopy.

Authors:  V K Singh; A K Rai; P K Rai; P K Jindal
Journal:  Lasers Med Sci       Date:  2008-12-23       Impact factor: 3.161

5.  Composition of urinary calculi by x-ray diffraction. Collected data from various localities. XII-XIV. Northern Ireland, South Africa and Kuwait.

Authors:  D J Sutor; S E Wooley
Journal:  Br J Urol       Date:  1972-06

6.  An observation on the analysis of urinary calculi by infrared spectroscopy.

Authors:  E Takasaki
Journal:  Calcif Tissue Res       Date:  1971

7.  A combined qualitative and quantitative procedure for the chemical analysis of urinary calculi.

Authors:  A Hodgkinson
Journal:  J Clin Pathol       Date:  1971-03       Impact factor: 3.411

8.  Inhibitors of urinary stone formation in 40 recurrent stone formers.

Authors:  B François; R Cahen; B Pascal
Journal:  Br J Urol       Date:  1986-10

9.  The role of trace metals in calcium urolithiasis.

Authors:  J L Meyer; E E Angino
Journal:  Invest Urol       Date:  1977-03

10.  Type of renal calculi: variation with age and sex.

Authors:  Antonia Costa-Bauzá; Margarita Ramis; Vicente Montesinos; Felix Grases; Antonio Conte; Pedro Pizá; Enrique Pieras; Felix Grases
Journal:  World J Urol       Date:  2007-05-25       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.